Forodesine
- Generic Name
- Forodesine
- Drug Type
- Small Molecule
- Chemical Formula
- C11H14N4O4
- CAS Number
- 209799-67-7
- Unique Ingredient Identifier
- 426X066ELK
Overview
Forodesine is a highly potent, orally active, rationally designed PNP inhibitor that has shown activity in preclinical studies with malignant cells and clinical utility against T-cell acute lymphoblastic leukemia and cutaneous T-cell lymphoma. Additional preliminary findings support its use for the management of some B-cell malignancies.
Background
Forodesine is a highly potent, orally active, rationally designed PNP inhibitor that has shown activity in preclinical studies with malignant cells and clinical utility against T-cell acute lymphoblastic leukemia and cutaneous T-cell lymphoma. Additional preliminary findings support its use for the management of some B-cell malignancies.
Indication
Investigated for use/treatment in lymphoma (non-hodgkin's) and leukemia (lymphoid).
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
Singapore Approved Products
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.